SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001225208-17-010662
Filing Date
2017-06-01
Accepted
2017-06-01 10:03:55
Documents
2
Period of Report
2017-05-23

Document Format Files

Seq Description Document Type Size
1 doc3.html 3  
1 doc3.xml 3 9223
2 watsonpoa.txt EX-24 2869
  Complete submission text file 0001225208-17-010662.txt   13564
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address
Watson Ashley (Reporting) CIK: 0001708109 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-06571 | Film No.: 17883618